Novel Imaging Model Helps Reveal New Therapeutic Target for Pancreatic Cancer

Antisense treatment in preclinical models shows effectiveness against deadly tumors —

Pancreatic ductal adenocarcinoma, the most common of pancreatic cancers, is extraordinarily lethal, with a 5-year survival rate of just 6 percent. Chemotherapy treatments are poorly effective, in part due to a high degree of drug-resistance to currently used regimens.

In a new study, published online June 6 in Nature, researchers at University of California San Diego School of Medicine and Moores Cancer Center, together with colleagues at Keio University, the University of Nebraska and Ionis Pharmaceuticals describe an innovative new model that not only allowed them to track drug resistance in vivo, but also revealed a new therapeutic target … Read the Full Story from the UC San Diego Newsroom

Tannishtha Reya, PhD, Professor of Medicine in the Division of Hematology-Oncology and Professor of Pharmacology, was co-principal investigator of the project.

Dr. Frederick D. Park

Dr. Frederick D. Park

Another Department of Medicine coauthor was Frederick D. Park, MD, PhD, Assistant Professor in the Division of Gastroenterology.

Study Finds Potential New Drug Therapy for Crohn’s Disease

Ustekinumab Induces, Sustains Clinical Response in Patients

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results in decreasing the debilitating effects of Crohn’s Disease, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the October 18, 2012 issue of the New England Journal of MedicineRead the full story from the UCSD Newsroom

Dr. William J. SandbornThe principal investigator of the study is Dr. William J. Sandborn, professor of medicine and chief of the Division of Gastroenterology at UCSD.  |  Read his academic profile  |  Read his clinical profile

Read the report of the study in the New England Journal of Medicine (full text UCSD only)

Citation of study report:  Sandborn WJ, Gasink C, Gao L-L, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P,  Ghosh S, de Villiers WJS, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG for the CERTIFI Study Group. N Engl J Med 2012; 367:1519-1528 October 18, 2012 DOI: 10.1056/NEJMoa1203572

Dr. Anthony N. DeMaria receives Einthoven Medal

Anthony N. DeMaria, M.D., has received the prestigious Einthoven Medal and delivered the 28th annual Einthoven Lecture in Leiden, The Netherlands, in January.

The lectureship and medal honored Dr. DeMaria for his contributions in cardiac imaging. They were presented during the 4th Leiden Cardiology Course at the Leiden University Medical Center.

Dr. DeMaria is Professor of Medicine, Judith and Jack White Chair in Cardiology and Head of the Sulpizio Family Cardiovascular Center at UC San Diego Medical Center.

Read the full story
from the Einthoven Foundation Cardiology Information Portal

More Information